You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

 

CME / CE

Educating Community Clinicians to Optimize Molecular Testing Practices for Patients With Newly Diagnosed Advanced NSCLC

  • Authors: Jared Weiss, MD
  • CME / CE Released: 11/1/2023
  • Valid for credit through: 11/1/2024, 11:59 PM EST
Start Activity

  • Credits Available

    Physicians - maximum of 0.50 AMA PRA Category 1 Credit(s)™

    Nurses - 0.50 ANCC Contact Hour(s) (0 contact hours are in the area of pharmacology)

    Physician Assistant - 0.50 AAPA hour(s) of Category I credit

    IPCE - 0.50 Interprofessional Continuing Education (IPCE) credit

    You Are Eligible For

    • Letter of Completion

Target Audience and Goal Statement

This activity is intended for oncologists, nurse practitioners, physician assistants, and other members of the interprofessional team who manage oncology patients in the community setting.

The goal of this activity is for learners to have greater awareness about the importance of broad-based molecular testing in treatment decision-making for patients with newly diagnosed advanced non-small cell lung cancer (NSCLC).

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Importance of molecular testing for patients with newly diagnosed advanced NSCLC
    • Impact of continuing education initiatives to improve molecular testing practices and treatment selection
  • Demonstrate greater confidence in their ability to
    • Understand the utility of ordering either tissue or liquid molecular testing before starting first-line treatment for patients with advanced NSCLC


Disclosures

Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.


Faculty

  • Jared Weiss, MD

    Professor of Medicine
    Division of Oncology
    Lineberger Comprehensive Cancer Center
    University of North Carolina, Chapel Hill
    Chapel Hill, North Carolina

    Disclosures

    Jared Weiss, MD, has the following relevant financial relationships: 
    Consultant or advisor for: BeiGene (Beijing) Co., Ltd; EMD Serono; Genmab; Gilead Sciences, Inc.; Merck; Nanobiotix; Sanofi; Vesselon
    Research funding from: AstraZeneca Pharmaceuticals LP; Boehringer Ingelheim Pharmaceuticals, Inc.; Loxo/Lilly; Merck; Mirati; PDS Biotech; SDP Oncology 
    Stock options from: Vesselon
    Owns stock (publicly traded) in: Achilles Therapeutics PLC; Alnylam Pharmaceuticals, Inc.; Lyell Immunopharma Inc.; Merus NV; Nektar Therapeutics; Nuvalent Inc; Vertex Pharmaceuticals

Editor

  • Yoji Yamaguchi, MA, ELS

    Scientific Content Manager, Medscape, LLC

    Disclosures

    Yoji Yamaguchi, MA, ELS, has no relevant financial relationships.

Compliance Reviewer/Nurse Planner

  • Leigh Schmidt, MSN, RN, CNE, CHCP

    Associate Director, Accreditation and Compliance, Medscape, LLC

    Disclosures

    Leigh Schmidt, MSN, RN, CNE, CHCP, has no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has no relevant financial relationships.


Accreditation Statements

Medscape

Interprofessional Continuing Education

In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

IPCE

This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education (IPCE) credit for learning and change.

    For Physicians

  • Medscape, LLC designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™ . Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    College of Family Physicians of Canada Mainpro+® participants may claim certified credits for any AMA PRA Category 1 credit(s)™, up to a maximum of 50 credits per five-year cycle. Any additional credits are eligible as non-certified credits. College of Family Physicians of Canada (CFPC) members must log into Mainpro+® to claim this activity.

    Contact This Provider

    For Nurses

  • Awarded 0.50 contact hour(s) of nursing continuing professional development for RNs and APNs; 0.00 contact hours are in the area of pharmacology.

    Contact This Provider

  • For Physician Assistants

    Medscape, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits. Approval is valid until 10/31/2024. PAs should only claim credit commensurate with the extent of their participation.

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 70% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read about the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or print it out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate, but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period, you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CME / CE

Educating Community Clinicians to Optimize Molecular Testing Practices for Patients With Newly Diagnosed Advanced NSCLC

Authors: Jared Weiss, MDFaculty and Disclosures

CME / CE Released: 11/1/2023

Valid for credit through: 11/1/2024, 11:59 PM EST

processing....

Learning Feedback Questions

Please answer the questions below to self-assess your knowledge. Answering these questions again after the activity will allow you to see what you learned.

  • Print